Evidence map›Paper›PMID 35088415›Full record

ArticleBritish journal of pharmacology2022

Tricyclic antipsychotics and antidepressants can inhibit α5-containing GABA

Konstantina Bampali, Filip Koniuszewski, Luca L Silva, Sabah Rehman, Florian D Vogel, Thomas Seidel, Petra Scholze, Florian Zirpel, Arthur Garon, Thierry Langer and 2 more

Open access · hybridAbstract read
In one paragraph

Article in British journal of pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Journal of chemical information and modeling · 2023
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Konstantina BampaliDepartment of Pathobiology of the Nervous System, Center for Brain Research, Medical University Vienna, Vienna, Austria.ORCID 0000-0001-5063-4675
Filip KoniuszewskiDepartment of Pathobiology of the Nervous System, Center for Brain Research, Medical University Vienna, Vienna, Austria.ORCID 0000-0001-5946-3147
Luca L SilvaDepartment of Pathobiology of the Nervous System, Center for Brain Research, Medical University Vienna, Vienna, Austria.ORCID 0000-0002-6506-8976
Sabah RehmanDepartment of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Florian D VogelDepartment of Pathobiology of the Nervous System, Center for Brain Research, Medical University Vienna, Vienna, Austria.ORCID 0000-0002-5572-217X
Thomas SeidelDepartment of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
Petra ScholzeDepartment of Pathobiology of the Nervous System, Center for Brain Research, Medical University Vienna, Vienna, Austria.ORCID 0000-0003-4984-6034
Florian ZirpelDepartment of Pathobiology of the Nervous System, Center for Brain Research, Medical University Vienna, Vienna, Austria.
Arthur GaronDepartment of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
Thierry LangerDepartment of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
Matthäus WilleitDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-8418-6188
Margot ErnstDepartment of Pathobiology of the Nervous System, Center for Brain Research, Medical University Vienna, Vienna, Austria.ORCID 0000-0002-9809-2649
Medical University of Vienna · ATUniversity of Vienna · AT

Funding

Austrian Science Fund FWF W 1232
6 · The paper itself

Abstract

background and purposeMany psychotherapeutic drugs, including clozapine, display polypharmacology and act on GABA EXPERIMENTAL APPROACH: Functional studies of effects by seven antipsychotic and antidepressant medications were performed in several GABA KEY

resultsThe antipsychotic drugs clozapine and chlorpromazine exerted functional inhibition on multiple GABA CONCLUSION AND IMPLICATIONS: Despite high molecular and functional similarities among the tested ligands, they reduce GABA currents by differential usage of allosteric and orthosteric sites. The chlorpromazine site we describe here is a new potential target for optimizing antipsychotic medications with beneficial polypharmacology. Further studies in defined subtypes are needed to substantiate mechanistic links between the therapeutic effects of clozapine and its action on certain GABA

Indexed as

Antipsychotic AgentsClozapineAntidepressive AgentsChlorpromazinegamma-Aminobutyric AcidHumansLigandsReceptors, GABA-AAntidepressive AgentsAntipsychotic AgentsChlorpromazineClozapinegamma-Aminobutyric AcidLigandsReceptors, GABA-Aallosteric modulationantipsychoticschlorpromazineclozapinefunctional inhibitionGABAA receptor

Identifiers

PMID35088415
PMCPMC9314015
OpenAlexW4210780209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.